Constitution Capital LLC Abb Vie Inc. Transaction History

Constitution Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 11, 2024	SELL	$137.6 - $154.97 $68,800 - $77,485	-500 Reduced 16.67%	2,500 $387,000
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $14,461 - $16,654	-100 Reduced 3.23%	3,000 $478,000
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $55,324 - $66,348	400 Added 14.81%	3,100 $501,000
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $80,526 - $92,358	600 Added 28.57%	2,700 $362,000
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $52,791 - $65,500	400 Added 23.53%	2,100 $340,000
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $182,631 - $231,081	1,700 New	1,700 $230,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Constitution Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Constitution Capital LLC with notifications on news.